J&J Vaccine May Be Approved Soon in India

Thursday, September 16, 2021

/ by mansuralisaha

The News Cover: Currently in India, six vaccines have been approved for use. These are : Covishield, COVAXIN, Sputnik V, Moderna, ZyCoV-D and Janssen. Janssen is a COVID-19 vaccine developed by the company Johnson & Johnson Unlike the other 5 vaccines, the Janssen vaccine is a single-dose vaccine. Jansen had been granted Emergency Use Approval by the DCGI on 7 August. So why is Janssen a single-dose vaccine being implemented in India when we already have other 2 dose vaccines? In India, there are many people who live in mountains, rural areas while some are homeless. Traveling long distances for the second dose of the vaccine becomes difficult for such people. Some can't afford to travel for the 2nd dose. Janssen will be better as being a single-dose vaccine they will not have to travel for the second dose. 

The vaccine can be stored at 2-8°C. The vaccine is 85.4% effective in preventing COVID infection. If the person is infected then it is 93% effective in preventing hospitalization. However, there may be a 7% chance of hospitalization. In regards to side-effects, earlier there had been concerns about a blood clot risk but the European Medicines Agency has said that it is a very rare side-effect. In India it is being manufactured in collaboration with a Hyderabad-based company named Biological E. Earlier, it was reported that Janssen will be rolled out by October for mass vaccination. According to the government's rules, Janssen being a foreign vaccine will be tested first before it is approved for vaccination. 35 lakh doses have been sent to Kasauli, Himachal Pradesh to the CDL, which is India's top testing laboratory. The Health Ministry said the Janssen vaccine will be administered to 100 participants first. After analyzing those 100 participants for seven days, the CDL will approve the vaccine for mass vaccination.

No comments

Post a Comment

News Cover © all rights reserved
made with by templateszoo